FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 353:1-5 July 7, 2005 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Interview Supplementary Video Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article PubMed Citation

Embryonic stem-cell research, more than virtually any other scientific field, has been mired in political and ethical controversy. In recent weeks, however, important movement has occurred on ethical, scientific, and political fronts alike. First, at the end of April, the National Research Council and the Institute of Medicine (two branches of the National Academies, a nongovernmental scientific advisory body) issued new ethics guidelines for the conduct of such research, which were enthusiastically welcomed by scientists and policymakers.

Then, in mid-May, a Korean research team announced that they had derived lines of human embryonic stem cells carrying the genetic signatures of . . . [Full Text of this Article]

Source Information

Dr. Okie is a contributing editor of the Journal.

An interview with stem-cell researcher John Gearhart can be heard at www.nejm.org.

This article has been cited by other articles:

• Gruen, L., Grabel, L. (2006). Concise Review: Scientific and Ethical Roadblocks to Human Embryonic Stem Cell Therapy. Stem Cells 24: 2162-2169 [Abstract] [Full Text]  
• Committee on Infectious Diseases, (2006). Prevention of Pertussis Among Adolescents: Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine. Pediatrics 117: 965-978 [Abstract] [Full Text]